<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
 <channel>
  <title>Innogenetics N.V. - Latest News from rapidmicrobiology</title>
  <link>http://www.rapidmicrobiology.com/Companies/853.php</link>
  <description>Visit Innogenetics N.V. pages on rapidmicrobiology for news releases and general company information</description>
  <language>en-gb</language>
  <copyright>Copyright (C)2007 MicroLink. All rights reserved.</copyright>
  <lastBuildDate>Mon, 16 Jul 2007 12:38:02 GMT</lastBuildDate>
  <image>
    <title>rapidmicrobiology</title>
    <url>http://www.rapidmicrobiology.com/gif/rapmicro.GIF</url>
    <link>http://www.rapidmicrobiology.com/</link>
    <width>180</width>
    <height>50</height>
  </image>

  <item>
    <title>Innogenetics moves into human papillomavirus (HPV) diagnostics</title>
    <description>The new assay, the INNO-LiPA HPV Genotyping CE, is expected to obtain formal CE-marking* in early autumn.</description>
    <pubDate>Tue, 05 Sep 2006 15:29:43 GMT</pubDate>
    <category>Company News</category>
    <link>http://www.rapidmicrobiology.com/news/853h3.php</link>
  </item>

  <item>
    <title>Innogenetics Acquires Full PCR License from Roche Diagnostics</title>
    <description>Innogenetics and Roche Diagnostics have signed an agreement by which Roche has granted Innogenetics a full, worldwide license for the ...</description>
    <pubDate>Mon, 17 Oct 2005 07:30:00 GMT</pubDate>
    <category>Company News</category>
    <link>http://www.rapidmicrobiology.com/news/853h2.php</link>
  </item>

  <item>
    <title>New HIV-1 Resistance Assays (LiPA) Comparable to Existing Genotype Resistance Tests</title>
    <description>Findings from a recent study concluded that the VERSANT HIV-1 Resistance Assays (LiPA) produced comparable results to DNA sequencing in ...</description>
    <pubDate>Wed, 10 Jul 2002 07:30:00 GMT</pubDate>
    <category>Company News</category>
    <link>http://www.rapidmicrobiology.com/news/853h1.php</link>
  </item>

  <item>
    <title>Innogenetics receives 2 million euro milestone payment from Bayer</title>
    <description>Innogenetics N.V. has announced receipt of a milestone payment from Bayer Corporation. The 2 million euro payment confirms the completion ...</description>
    <pubDate>Wed, 26 Jun 2002 07:30:00 GMT</pubDate>
    <category>Company News</category>
    <link>http://www.rapidmicrobiology.com/news/853h0.php</link>
  </item>

 </channel>
</rss>
